Efficacy of gold nanoparticles against isoproterenol induced acute myocardial infarction in adult male albino rats

References

• Dominguez-Rodriguez A, Abreu-Gonzalez P, Reiter RJ. Cardioprotection and pharmacological therapies in acute myocardial infarction: challenges in the current era. World J Cardiol. 2014;6(3):100–106.
   PubMedGoogle Scholar
• Li L, Zhang LK, Chen L, Wang X, Zhang J. Cardioprotective effects of ghrelin and des‐octanoyl ghrelin on myocardial injury induced by isoproterenol in rats. Acta Pharmacol Sin. 2006;27(5):527–535.
   PubMed Web of Science ®Google Scholar
• Jagadeesh GS, Nagoor Meeran MF, Selvaraj P. Protective effects of 7‐hydroxycoumarin on dyslipidemia and cardiac hypertrophy in isoproterenol‐induced myocardial infarction in rats. J Biochem Mol Toxicol. 2015;30(3):120–127.
   PubMed Web of Science ®Google Scholar
• Neri M, Fineschi V, Di Paolo M, et al. Cardiac oxidative stress and inflammatory cytokines response after myocardial infarction. Curr Vasc Pharmacol. 2015;13(1):26–36.
   PubMed Web of Science ®Google Scholar
• Kelly RA, Balligand JL, Smith TW. Nitric oxide and cardiac function. Circ Res. 1996;79:363–380.
   PubMed Web of Science ®Google Scholar
• Tamargo J, Caballero R, Gomez R, Delpon E. Cardiac electrophysiological effects of nitric oxide. Cardiovasc Res. 2010;87:593–600.
   PubMed Web of Science ®Google Scholar
• Jones SP, Greer JJ, Kakkar AK, et al. Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury. Am J Physiol Heart Circ Physiol. 2004;286:H276–H282.
   PubMed Web of Science ®Google Scholar
• Pott C, Steinritz D, Bolck B, et al. eNOS translocation but not eNOS phosphorylation is dependent on intracellular Ca2+ in human atrial myocardium. Am J Physiol Cell Physiol. 2006;290:C1437–C1445.
   PubMed Web of Science ®Google Scholar
• Crespo MJ, Zalacaín J, Dunbar DC, Cruz N, Arocho L. Cardiac oxidative stress is elevated at the onset of dilated cardiomyopathy in streptozotocin-diabetic rats. J Cardiovasc Pharmacol Ther. 2008;13(1):64–71.
   PubMed Web of Science ®Google Scholar
• Spivak MY, Bubnov RV, Yemets IM, Lazarenko LM, Tymoshok NO, Ulberg ZR. Development and testing of gold nanoparticles for drug delivery and treatment of heart failure: a theranostic potential for PPP cardiology. EPMA J. 2013;4(1):1.
   PubMedGoogle Scholar
• Huang X, El-Sayed MA. Gold nanoparticles: optical properties and implementations in cancer diagnosis and photothermal therapy. J Adv Res. 2010;1(1):13–28.
   Google Scholar
• Sperling RA, Gil PR, Zhang F, Zanella M, Parak WJ. Biological applications of gold nanoparticles. Chem Soc Rev. 2008;37(9):1896–1908.
   PubMed Web of Science ®Google Scholar
• Haes AJ, Hall WP, Chang L, Klein WL, Van Duyne RP. A localized surface plasmon resonance biosensor: First steps toward an assay for Alzheimer’s disease. Nano Lett. 2004;4(6):1029–1034.
   Web of Science ®Google Scholar
• Haes AJ, Chang L, Klein WL, Van Duyne RP. Detection of a biomarker for Alzheimer’s disease from synthetic and clinical samples using a nanoscale optical biosensor. J Am Chem Soc. 2005;127(7):2264–2271.
   PubMed Web of Science ®Google Scholar
• Baptista PV, Koziol-Montewka M, Paluch-Oles J, Doria G, Franco R. Gold-nanoparticle-probe–based assay for rapid and direct detection of Mycobacterium tuberculosis DNA in clinical samples. Clin Chem. 2006;52(7):1433–1434.
   PubMed Web of Science ®Google Scholar
• Giannitrapani L, Soresi M, Bondì ML, Montalto G, Cervello M. Nanotechnology applications for the therapy of liver fibrosis. World J Gastroenterol. 2014;20(23):7242–7251.
   PubMed Web of Science ®Google Scholar
• Yang C, Tian A, Li Z. Reversible cardiac hypertrophy induced by PEG-coated gold nanoparticles in mice. Sci Rep. 2016;6:20203. DOI:10.1038/srep20203.
   PubMed Web of Science ®Google Scholar
• Sun SJ, Wu XP, Song HL, Li GQ. Baicalin ameliorates isoproterenol-induced acute myocardial infarction through iNOS, inflammation, oxidative stress and P38MAPK pathway in rat. Int J Clin Exp Med. 2015;8(12):22063–22072.
   PubMed Web of Science ®Google Scholar
• Bancroft J, Layton C. The Hematoxylin and eosin. In: Suvarna SK, Layton C, Bancroft JD, ed. Theory and Practice of Histological Techniques. 7th ed. Philadelphia: Churchill Livingstone of El Sevier, Ch. 10 and 11; 2013:172–214.
   Google Scholar
• Drury RA, Wallington EA. Carlton’s Histological Techniques. 5th ed. Oxford: Oxford University Press; 1980.
   Google Scholar
• Ramos-Vara JA, Kiupel M, Baszier T, et al. Suggested guidelines for immunohistochemical techniques in veterinary diagnostic laboratories. J Vet Diagn Invest. 2008;20:393–413.
   PubMed Web of Science ®Google Scholar
• Glauert AM, Lewis PR. Biological Specimen Preparation for Transmission Electron Microscopy. 1st ed. London: Portland Press; 1998.
   Google Scholar
• Jong WH, Burger MC, Verheijen MA, Geertsma RE. Detection of the presence of gold nanoparticles in organs by transmission electron microscopy. Materials 2010;3(9):4681–4694.
   PubMed Web of Science ®Google Scholar
• Abozeid AA, Abou Fard GM, Shafik NM. Effect of systemic Ghrelin administration on experimental myocardial infarction induced by isoproterenol in rats. Bull Egypt Soc Physiol Sci. 2014;34(1):43–56.
   Google Scholar
• Patel V, Upaganlawar A, Zalawadia R, Balaraman R. Cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats: a biochemical, electrocardiographic and histoarchitectural evaluation. Eur J Pharmacol. 2010;644(1):160–168.
   PubMed Web of Science ®Google Scholar
• Hussain Shaik A, Rasool SN, Kareem MA, Krushna GS, Akhtar PM, Devi KL. Maslinic acid protects against isoproterenol-induced cardiotoxicity in albino Wistar rats. J Med Food. 2012;15(8):741–746.
   PubMed Web of Science ®Google Scholar
• Vijayan NA, Thiruchenduran M, Devaraj SN. Anti-inflammatory and anti-apoptotic effects of Crataegus oxyacantha on isoproterenol-induced myocardial damage. Mol. Cell. Biochem. 2012;367(1–2):1–8.
   PubMed Web of Science ®Google Scholar
• Euteneuer F, Mills PJ, Rief W, Ziegler MG, Dimsdale JE. Association of in vivo beta-adrenergic receptor sensitivity with inflammatory markers in healthy subjects. Psychosomatic Med. 2012;74(3):271.
   PubMed Web of Science ®Google Scholar
• Moradi-Arzeloo M, Farshid AA, Tamaddonfard E, Asri-Rezaei S. Effects of histidine and vitamin C on isoproterenol-induced acute myocardial infarction in rats. Vet Res Forum. 2016;7(1):47. Faculty of Veterinary Medicine, Urmia University, Urmia, Iran.
   Google Scholar
• Li H, Xie YH, Yang Q, et al. Cardioprotective effect of paeonol and danshensu combination on isoproterenol-induced myocardial injury in rats. PloS One. 2012;7(11):e48872.
   PubMed Web of Science ®Google Scholar
• Gao Y, Hao J, Zhang H, et al. Protective effect of the combinations of glycyrrhizic, ferulic and cinnamic acid pretreatment on myocardial ischemia-reperfusion injury in rats. Exp Ther Med. 2015;9(2):435–445.
   PubMed Web of Science ®Google Scholar
• Mill JG, Stefanon I, dos Santos L, Baldo MP. Remodeling in the ischemic heart: the stepwise progression for heart failure. Braz J Med Biol Res 2011 Sep;44(9):890–898.
   Google Scholar
• Rajappa M, Sen SK, Sharma A. Role of pro-/anti-inflammatory cytokines and their correlation with established risk factors in South Indians with coronary artery disease. Angiology 2009;60:419.
   PubMed Web of Science ®Google Scholar
• Del Monte U. Swelling of hepatocytes injured by oxidative stress suggests pathological changes related to macromolecular crowding. Med Hypotheses 2005;64(4):818–825.
   PubMed Web of Science ®Google Scholar
• Stanely Mainzen Prince P, Karthick M. Preventive effect of rutin on lipids, lipoproteins, and ATPases in normal and isoproterenol‐induced myocardial infarction in rats. J Biochem Mol Toxicol. 2007;21(1):1–6.
   PubMed Web of Science ®Google Scholar
• Bharti S, Arora S, Arya DS. Evaluation of morphological changes in experimental models of myocardial infarction: electron and light microscopical evidence. In: Méndez-Vilas A, Díaz J, eds. Microscopy Book Series No. 4 Volume 1, Microscopy: Science, Technology, Applications and Education. New Delhi, India: FORMATEX; 2010:361–371.
   Google Scholar
• Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small. 2005;1(3):325–327.
   PubMed Web of Science ®Google Scholar
• Zhang XD, Wu HY, Wu D, et al. Toxicologic effects of gold nanoparticles in vivo by different administration routes. Int J Nanomed. 2010;5:771–781.
   PubMed Web of Science ®Google Scholar
• Abdelhalim MA. Exposure to gold nanoparticles produces cardiac tissue damage that depends on the size and duration of exposure. Lipids Health Dis. 2011;10(1):1.
   Web of Science ®Google Scholar
• Yang C, Yang H, Wu J, et al. No overt structural or functional changes associated with PEG-coated gold nanoparticles accumulation with acute exposure in the mouse heart. Toxicol Lett. 2013;222(2):197–203.
   PubMed Web of Science ®Google Scholar
• Abdelhalim MAK. Uptake of gold nanoparticles in several rat organs after intraperitoneal administration in vivo: a fluorescence study. Bio Med Res Int. 2013;2013. DOI:10.1155/2013/353695.
   Web of Science ®Google Scholar
• Burlew BS, Weber KT. Connective tissue and the heart: functional significance and regulatory mechanisms. Cardiol Clin. 2000;18(3):435–442.
   PubMedGoogle Scholar
• Bisht S, Khan MA, Bekhit M, et al. A polymeric nanoparticle formulation of curcumin (NanoCurc™) ameliorates CCl4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation. Lab Invest. 2011;91:1383–1395.
   PubMed Web of Science ®Google Scholar
• Toyama T, Nakamura H, Harano Y, et al. PPAR alpha ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats. Biochem Biophys Res Commun. 2004;324:697–704.
   PubMed Web of Science ®Google Scholar
• Chen H, He YW, Liu WQ, Zhang JH. Rosiglitazone prevents murine hepatic fibrosis induced by Schistosoma japonicum. World J Gastroenterol. 2008;14:2905–2911.
   PubMed Web of Science ®Google Scholar
• Thakor AS, Jokerst J, Zavaleta C, Massoud TF, Gambhir SS. Gold nanoparticles: a revival in precious metal administration to patients. Nano Lett. 2011;11(10):4029–4036.
   PubMed Web of Science ®Google Scholar
• Khan MS, Vishakante GD, Siddaramaiah H. Gold nanoparticles: a paradigm shift in biomedical applications. Adv Colloid Interface Sci. 2013;199:44–58.
   PubMed Web of Science ®Google Scholar
• van Nieuwenhoven FA, Turner NA. The role of cardiac fibroblasts in the transition from inflammation to fibrosis following myocardial infarction. Vasc Pharmacol. 2013;58(3):182–188.
   PubMed Web of Science ®Google Scholar
• Zaitone SA, Abo-Gresha NM. Rosuvastatin promotes angiogenesis and reverses isoproterenol-induced acute myocardial infarction in rats: role of iNOS and VEGF. Eur J Pharmacol. 2012;691(1):134–142.
   PubMed Web of Science ®Google Scholar
• Megson IL, Haw SJ, Newby DE, Pell JP. Association between exposure to environmental tobacco smoke and biomarkers of oxidative stress among patients hospitalised with acute myocardial infarction. PloS One. 2013;8(12):e81209.
   PubMed Web of Science ®Google Scholar
• Perrelli MG, Pagliaro P, Penna C. Ischemia/reperfusion injury and cardioprotective mechanisms: role of mitochondria and reactive oxygen species. World J Cardiol. 2011;3(6):186–200.
   PubMedGoogle Scholar
• Garg M, Khanna D. Exploration of pharmacological interventions to prevent isoproterenol-induced myocardial infarction in experimental models. Ther Adv Cardiovasc Dis. 2014;8(4):155–169.
   PubMedGoogle Scholar
• Kannan MM, Quine SD. Ellagic acid inhibits cardiac arrhythmias, hypertrophy and hyperlipidaemia during myocardial infarction in rats. Metabolism. 2013;62:52–61.
   PubMed Web of Science ®Google Scholar
• Jordan JE, Zhao ZQ, Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res. 1999;43:860–878.
   PubMed Web of Science ®Google Scholar
• BarathManiKanth S, Kalishwaralal K, Sriram M, et al. Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice. J Nanobiotechnol. 2010;8(1):1.
   PubMedGoogle Scholar
• Shukla R, Bansal V, Chaudhary M, Basu A, Bhonde RR, Sastry M. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir. 2005;21(23):10644–10654.
   PubMed Web of Science ®Google Scholar
• Álvaro M, Aprile C, Corma A, Ferrer B, García H. Influence of radical initiators in gold catalysis: evidence supporting trapping of radicals derived from azobis (isobutyronitrile) by gold halides. J Catal. 2007;245(1):249–252.
   Web of Science ®Google Scholar
• Yakimovich NO, Ezhevskii AA, Guseinov DV, Smirnova LA, Gracheva TA, Klychkov KS. Antioxidant properties of gold nanoparticles studied by ESR spectroscopy. Russ Chem Bull. 2008;57(3):520–523.
   Web of Science ®Google Scholar
• Nelson BC, Petersen EJ, Marquis BJ, et al. NIST gold nanoparticle reference materials do not induce oxidative DNA damage. Nanotoxicology 2013;7(1):21–29.
   PubMed Web of Science ®Google Scholar
• Technical Palojoki E, Saraste A, Eriksson A, et al. Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am J Physiol-Heart Circulatory Physiol. 2001;280(6):H2726–H2731.
   PubMed Web of Science ®Google Scholar
• Kajstura J, Cheng W, Reiss K, et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest J Tech Methods Pathol. 1996;74(1):86–107.
   PubMed Web of Science ®Google Scholar
• Akasaka Y, Morimoto N, Ishikawa Y, et al. Myocardial apoptosis associated with the expression of proinflammatory cytokines during the course of myocardial infarction. Mod Pathol. 2006;19(4):588–598.
   PubMed Web of Science ®Google Scholar
• Tsujimoto Y. Role of Bcl‐2 family proteins in apoptosis: apoptosomes or mitochondria? Genes Cells 1998;3(11):697–707.
   PubMed Web of Science ®Google Scholar
• Condorelli G, Morisco C, Stassi G, et al. Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the rat. Circulation. 1999; 99(23):3071–3078.66- Farvin KS, Anandan R, Kumar SH, Shiny KS, Sankar TV, Thankappan TK. Effect of squalene on tissue defense system in isoproterenol-induced myocardial infarction in rats. Pharmacol Res. 2004;50(3):231–236.
   PubMed Web of Science ®Google Scholar
• Liu Q, Zhang J, Xu Y, Huang Y, Wu C. Effect of carvedilol on cardiomyocyte apoptosis in a rat model of myocardial infarction: a role for toll-like receptor 4. Indian J Pharmacol. 2013;45(5):458.
   PubMed Web of Science ®Google Scholar
• Liu Z, Shen Y, Wu Y, et al. An intrinsic therapy of gold nanoparticles in focal cerebral ischemia-reperfusion injury in rats. J Biomed Nanotechnol. 2013;9(6):1017–1028.
   PubMed Web of Science ®Google Scholar
• El-Mehy AE. Histological and immunohistochemical study on the effect of doxorubicin on the heart of adult albino rat and the possible protective role of an antioxidant beer E. El-Mehy; Fouad K. Mansour; Nariman A. Abd El-Fattah; Fatma A. El-Safty and Mohamed M. El-Fiky. MMJ. 2008;21(1):91–108.
   Google Scholar
• Nagoor Meeran MF, Stanely Mainzen Prince P. Protective effects of N‐acetyl cysteine on membrane‐bound adenosine triphosphatases and minerals in isoproterenol‐induced myocardial‐infarcted rats: an in vivo and in vitro study. J Biochem Mol Toxicol. 2012;26(7):276–281.
   PubMed Web of Science ®Google Scholar
• Meeran N, Fizur M, Stanely Mainzen Prince P. Protective effects of thymol on altered plasma lipid peroxidation and nonenzymic antioxidants in isoproterenol‐induced myocardial infarcted rats. J Biochem Mol Toxicol. 2012;26(9):368–373.
   PubMed Web of Science ®Google Scholar
• Farvin KS, Anandan R, Kumar SH, Shiny KS, Sankar TV, Thankappan TK. Effect of squalene on tissue defense system in isoproterenol-induced myocardial infarction in rats. Pharmacol Res. 2004;50(3):231–236.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. J Am College Cardiol. 2007;50(22):2173–2195.
   PubMed Web of Science ®Google Scholar
• Arya DS, Bansal P, Ojha SK, Nandave M, Mohanty I, Gupta SK. Pyruvate provides cardioprotection in the experimental model of myocardial ischemic reperfusion injury. Life Sci. 2006;79(1):38–44.
   PubMed Web of Science ®Google Scholar